Fig. 2From: Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and NorwayMean EQ-VAS by number of headache days per month. Key: HA, headacheBack to article page